Journals / Clinical and Experimental Health Sciences / 2022 / Cilt: 12 - Sayı: 4

Monocyte to HDL Ratio in Preeclamptic Patients: Can It Be a Predictive Marker?

Pages
835–839
Publication Date
2022-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The gestational week at delivery was significantly earlier in the PE group than in the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Preeclampsia (PE) is a severe and high – risk pregnancy complication for both the mother and fetus.
📊
Key Findings & Data:Methods: A retrospective case-control study was recruited preeclamptic and healthy pregnant women in the third trimester of gestation (n=69 and n= 71, respectively).
💡
Conclusion & Impact:The gestational week at delivery was significantly earlier in the PE group than in the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:preeclampsia · monocyte · HDL

Abstract

Objective: Preeclampsia (PE) is a severe and high – risk pregnancy complication for both the mother and fetus. Generalized inflammation is a prominent feature of PE. Based on the proinflammatory property of monocytes and the contrary anti-inflammatory mechanism of High-density lipoprotein (HDL), monocyte count to HDL ratio (MHR) could be used as a new marker of systemic inflammation. Our aim is to evaluate the relationship between PE and MHR in terms of diagnosis of PE. Methods: A retrospective case-control study was recruited preeclamptic and healthy pregnant women in the third trimester of gestation (n=69 and n= 71, respectively). Results: Maternal age (years), gravity, and body mass index (BMI) were similar in the two groups. The gestational week at delivery was significantly earlier in the PE group than in the control group (p

🔖

Cite This Article

KÖPÜK, Ş. Y., NACİ, N., ÖZCAN, C., ULU, İ. (2022). Monocyte to HDL Ratio in Preeclamptic Patients: Can It Be a Predictive Marker?. Clinical and Experimental Health Sciences, Cilt: 12 - Sayı: 4, 835–839. https://ajindex.com/articles/858349

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Saito, S. Preeclampsia Basic, Genomic, and Clinical; Springer Nature Singapore Pte Ltd.: Singapore, 2018.
  2. Eiland E, Nzerue C, Faulkner M. Preeclampsia. J Pregnancy 2012. ID 586578. Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy 2012;2012: 105918. De Groot CJ, Taylor RN. New insights into the etiology of preeclampsia. Ann Med 1993;25(3):243–249.
  3. Ghio A, Bertolotto A, Resi V, Volpe L, Cianni GD. Triglyceride metabolism in pregnancy. Adv Clin Chem. 2011;55:133–153. doi: 10.1016/b978-0-12-387042-1.00007-1.
  4. Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983;4:397-413.
  5. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007;28(2):192-209. doi: 10.1016/j.mam.2007.02.006. Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 2006 Nov;80(5):1156-64.
  6. Epelman S, Lavine KJ, Randolph GJ. Origin and Functions of Tissue Macrophages. Immunity 2014;41(1): 21–35.
  7. Nonn O, Güttler J, Forstner D, Maninger S, Zadora J, Balogh A, Frolova A, Glasner A, Herse F, Gauster M. Placental CX3CL1 is deregulated by angiotensin II and contributes to a proinflammatory trophoblast-monocyte interaction. Int J Mol Sci. 2019; 20(3):641. doi: 10.3390/ijms20030641. Siwetz M, Sundl M, Kolb D, Hiden U, Herse F, Huppertz B, Gauster M. Placental fractalkine mediates adhesion of THP-1 monocytes to villous trophoblast. Histochem Cell Biol. 2015;143(6):565–574. doi: 10.1007/s00418.014.1304-0.
  8. Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, Turak O, Aras D, Aydogdu S. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost. 2016;22(5):476-482. doi: 10.1177/107.602.9615594002. Ertek S. High-density Lipoprotein (HDL) Dysfunction and the Future of HDL. Curr Vasc Pharmacol 2018; 16(5): 490–498.
  9. Ganjali S, Gotto AM, Ruscica M, Atkin SL, Butler AE, Banach M, Sahebkar A. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12): 9237–9246. doi: 10.1002/jcp.27028. Sibai B, Dekker G, Kupferminc M. Preeclampsia Lancet 2005;365:785–99.
  10. Faas MM, Vos PD. Maternal monocytes in pregnancy and preeclampsia in humans and in rats.